Jupiter Neurosciences Inc (JUNS) Stock Analysis
Verdict: AVOID
Severe cash burn ($5.4M/yr) and negative equity (-$1.83M) drive extreme dilution risk, making JUNS a high-risk speculative trap.
Investment score: 14/100
Analysis as of
Is Jupiter Neurosciences Inc stock worth reviewing? AI model thesis
The model issues an AVOID rating on Jupiter Neurosciences (JUNS). With an unsustainable cash runway of under 9 months, negative balance sheet equity, and a 23.68% single-day crash to $3.19, the stock carries prohibitive dilution and insolvency risks.
7-factor investment score
- Valuation: 10/100 (weight 20%)
- Financial Health: 5/100 (weight 15%)
- Technical Momentum: 10/100 (weight 15%)
- Earnings Quality: 20/100 (weight 15%)
- Insider Sentiment: 30/100 (weight 10%)
- Analyst Consensus: 25/100 (weight 10%)
- Risk-Adjusted Return: 10/100 (weight 15%)
Jupiter Neurosciences Inc opportunities and risks
What speaks for JUNS
- Phase II Clinical Progress
What speaks against JUNS
- Imminent Cash Depletion & Equity Dilution
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| JUNS | n/a | 24.6x | n/a | 88.3% | -14220.1% | -454.6% |
| KRTL | n/a | 2.1x | n/a | 56.2% | -304.4% | -38.1% |
| JAGX | n/a | 0.0x | n/a | 82.3% | -131.8% | -13302.9% |
| ECGS | n/a | 0.0x | n/a | 0.0% | 0.0% | 64.0% |
| SXTP | n/a | 0.8x | 0.0x | 19.4% | -730.2% | -1027.5% |
| BUDZ | n/a | 0.0x | n/a | 0.0% | 0.0% | -4.5% |
| Peer median | n/a | 0.0x | n/a | 19.4% | -131.8% | -38.1% |
Frequently asked questions about Jupiter Neurosciences Inc (JUNS)
Is JUNS stock a good investment?
The cached TradeMates AI model rates Jupiter Neurosciences Inc as AVOID with an investment score of 14/100. The model issues an AVOID rating on Jupiter Neurosciences (JUNS). With an unsustainable cash runway of under 9 months, negative balance sheet equity, and a 23.68% single-day crash to $3.19, the stock carries prohibitive dilution and insolvency risks. This is algorithmic model output, not personal investment advice.
Is JUNS stock a buy?
The TradeMates model verdict for JUNS is AVOID with an investment score of 14/100. Treat this as a model signal to review, not a personal buy recommendation.